Related Experiment Video
Updated: Dec 19, 2025

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
Published on: May 31, 2024
WHF IASC Roadmap on Chagas Disease
Luis Eduardo Echeverría1, Rachel Marcus2,3, Gabriel Novick4,5
1Department of Cardiology, Cardiovascular Foundation of Colombia, Floridablanca, CO.
Insights
Chagas disease, a neglected tropical illness, requires improved diagnosis and treatment strategies. This roadmap outlines solutions to overcome barriers in patient care, aiming for global eradication.
Area of Science:
- Global Health
- Infectious Diseases
- Cardiology
Background:
- Chagas disease (CD) is a neglected tropical disease caused by *Trypanosoma cruzi*, primarily affecting the cardiovascular system.
- It is a chronic, stigmatizing condition linked to poverty, impacting millions globally with a growing international presence.
- Characterized by a long asymptomatic phase, approximately 30% of infected individuals develop severe cardiac complications, including heart failure and stroke.
Purpose of the Study:
- To develop a comprehensive roadmap for the prevention, diagnosis, and management of Chagas disease.
- To identify and analyze obstacles hindering access to comprehensive care for Chagas disease patients.
- To propose evidence-based strategies and solutions for healthcare professionals, authorities, and governments to address these barriers.
Main Methods:
- Convened a diverse group of 20 Chagas disease experts from the World Heart Federation (WHF) and Inter-American Society of Cardiology (IASC).
- Conducted an extensive literature review on obstacles and solutions for CD diagnosis and treatment.
- Utilized a survey distributed to WHF Members and healthcare professionals, supplemented by snowball sampling, to gather broader community input.
Main Results:
- The WHF IASC Roadmap provides a comprehensive overview of current knowledge on Chagas disease prevention, diagnosis, and management.
- Analysis of 'roadblocks' in patient care access was conducted, considering healthcare system capabilities, governance, financing, community awareness, and advocacy.
- Consolidated findings from expert knowledge, literature review, and community surveys formed the basis of the roadmap.
Conclusions:
- The roadmap offers actionable strategies and evidence-based solutions to overcome barriers in comprehensive Chagas disease care.
- It outlines an ideal patient care pathway, highlighting challenges and proposing practical solutions.
- The document serves as a call to action for decision-makers and healthcare professionals to intensify efforts towards Chagas disease eradication.
Background:
Chagas Disease is a neglected tropical disease caused by the protozoan Trypanosoma cruzi, with some of the most serious manifestations affecting the cardiovascular system. It is a chronic, stigmatizing condition, closely associated with poverty and affecting close to 6 million people globally. Although historically the disease was limited to endemic areas of Latin America recent years have seen an increasing global spread. In addition to the morbidity and mortality associated with the disease, the social and economic burdens on individuals and society are substantial. Often called the 'silent killer', Chagas disease is characterized by a long, asymptomatic phase in affected individuals. Approximately 30% then go on develop chronic Chagas cardiomyopathy and other serious cardiac complications such as stroke, rhythm disturbances and severe heart failure.
Methods:
In a collaboration of the World Hearth Federation (WHF) and the Inter-American Society of Cardiology (IASC) a writing group consisting of 20 diverse experts on Chagas disease (CD) was convened. The group provided up to date expert knowledge based on their area of expertise. An extensive review of the literature describing obstacles to diagnosis and treatment of CD along with proposed solutions was conducted. A survey was sent to all WHF Members and, using snowball sampling to widen the consultation, to a variety of health care professionals working in the CD global health community. The results were analyzed, open comments were reviewed and consolidated, and the findings were incorporated into this document, thus ensuring a consensus representation.
Results:
The WHF IASC Roadmap on Chagas Disease offers a comprehensive summary of current knowledge on prevention, diagnosis and management of the disease. In providing an analysis of 'roadblocks' in access to comprehensive care for Chagas disease patients, the document serves as a framework from which strategies for implementation such as national plans can be formulated. Several dimensions are considered in the analysis: healthcare system capabilities, governance, financing, community awareness and advocacy.
Conclusion:
The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.
Related Concept Videos
Preclinical Development: Overview
Principles of Disease Surveillance
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Gene Therapy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Pancreatitis II: Collaborative Care
Assessment:

